Dr Amir Khan shares five symptoms of type 2 diabetes – including sign in feet
As many as 1.3million people in the UK may unknowingly be living with type 2 diabetes – but there are a few signs to watch ...
News Medical1d
Sotagliflozin could be used to reduce the risk of deadly cardiovascular events, trial shows
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
2025 Maserati GT2 Stradale First Drive: Fun & Frustration From This Porsche GT3 Rival
Maserati's lovable MC20 spawns a 911 GT3 rival, but does this expensive, road-legal track toy live up to its high-revving ...
MedPage Today1d
SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
Research shows sotagliflozin is the first medication of its kind to significantly reduce both heart attacks and strokes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
Maserati GT2 Stradale Is Almost Great
The MC20's turned-up sibling is lighter, more powerful, and faster—but something has been lost in translation.
Medical News Today1d
New test may detect Alzheimer's years before tau clumps show up in scans
Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...
PharmiWeb3d
Diabetes Drugs Market Forecasted to Reach US$ 177.74 Billion by 2034, Expanding at a CAGR of 7.7%
The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...